Keywords: VHD, gastro-intestinal graft-versus-host disease, Sigma-Tau

Soligenix shares decimated as firm puts hold on orBec development

Article | 20 September 2011

Print This

New Jersey, USA-based Soligenix (OTCBB: SNGX) saw its shares plummet 85% to just $0.03 last week, after the company said that an ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in